---
title: "BEIXIN: It is expected that the net profit loss in the first half of 2025 will be between 70 million yuan and 85 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248430203.md"
description: "BEIXIN announced that it is expected to incur a net loss attributable to shareholders of the listed company of 70 million to 85 million yuan from January 1, 2025, to June 30, 2025, compared to a profit of 10.5262 million yuan in the same period last year; the net profit after deducting non-recurring gains and losses is expected to be a loss of 75 million to 90 million yuan, compared to a loss of 1.8676 million yuan in the same period last year; the basic earnings per share are expected to be a loss of 0.0552 yuan/share to 0.067 yuan/share, compared to a profit of 0.0083 yuan/share in the same period last year"
datetime: "2025-07-14T12:23:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248430203.md)
  - [en](https://longbridge.com/en/news/248430203.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248430203.md)
generator: "portal-rs"
---

# BEIXIN: It is expected that the net profit loss in the first half of 2025 will be between 70 million yuan and 85 million yuan

BEIXIN announced that it expects a net loss attributable to shareholders of the listed company of RMB 70 million to 85 million from January 1, 2025, to June 30, 2025, compared to a profit of RMB 10.5262 million in the same period last year; the net profit after deducting non-recurring gains and losses is expected to be a loss of RMB 75 million to 90 million, compared to a loss of RMB 1.8676 million in the same period last year; the basic earnings per share are expected to be a loss of RMB 0.0552 to 0.067 per share, compared to a profit of RMB 0.0083 per share in the same period last year

### Related Stocks

- [002307.CN](https://longbridge.com/en/quote/002307.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [EU Commission grants Lundbeck orphan drug status for asedebart in endogenous Cushing’s syndrome](https://longbridge.com/en/news/296747576.md)
- [Navigator invests about EUR 115 million in new tissue paper machine at Aveiro complex](https://longbridge.com/en/news/296775961.md)
- [China says US transshipment report disregards facts](https://longbridge.com/en/news/296450742.md)
- [Trump warns of economic consequences for any country that supports Iran](https://longbridge.com/en/news/296409367.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**